Navigation Links
Bradmer announces 2008 third quarter operational and financial results
Date:11/10/2008

TSX: BMR

TORONTO, Nov. 10 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a clinical oncology company specializing in the development and commercialization of cancer therapies, today announced its 2008 third quarter operational and financial results.

Operational Highlights

During the three months ended September 30, 2008 and the period subsequent to this date, the Company achieved the following milestones related to its operations and its lead drug, Neuradiab(TM), which is being studied in the Phase III GLASS-ART(TM) Trial:

- Maintained budgetary control and reduced quarterly spending;

- Signed clinical study contracts with nine of the initial 16 sites

under active consideration and activated an initial cohort of five

sites, while advancing a pipeline of additional sites in the US

through the contractual, training and regulatory process;

- Initiated dialog with Health Canada for study expansion into key

Canadian sites with the support of the Canadian Brain Cancer

consortium;

- Enrolled the first group of patients in the GLASS-ART Trial and

successfully dosed patients with Neuradiab at multiple sites;

- Announced new data from the most recent Phase II trial indicating that

the mean time to progression free survival was 77 weeks, which

compares favorably with other published results in newly diagnosed

GBM;

- Evaluated a series of technical steps that may allow a two week

extension of the shelf life of Neuradiab beyond the current six-day

specification; and

- Appointed Dr. Donald Kufe, Professor of Medicine, Harvard Medical

School and Director, Experimental Therapeutics Program, Dana-

Farber/Harvard Cancer Center and Charles James Lilly, CA, a senior

partner with a public accounting firm, to the Board of Directors of

the Company.

"The treat
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Bradmer to present at Rodman & Renshaw Healthcare Conference
2. Bradmer receives FDA approval to proceed with Phase III clinical trial
3. Bradmer announces 2008 first quarter operational and financial results
4. Bradmer announces new additions to management team
5. Bradmer announces 2007 fourth quarter and fiscal year operational and financial results
6. Notice of Bradmer Pharmaceuticals Conference Call
7. Bradmer announces Phase II results published in newly diagnosed glioblastoma which demonstrate improved survival and support upcoming Phase III study
8. Bradmer to present at the 10th Annual BIO CEO & Investor Conference
9. Bradmer announces additions to Scientific Advisory Board
10. Bradmer Medical Isotope Supply For Phase III Trial Secure
11. Bradmer to present at Rodman & Renshaw Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... August 30, 2014 "My wife suffered ... a car accident," said one of two inventors from ... in her shoulder and neck area. She tried other ... pain and pressure, assisting in comfort and providing extra ... PILLOW CRADLE to support the head, neck and back ...
(Date:8/30/2014)... Serving contented clients since inception, #1 ... Outsourcing is now offering discount for Labor Day ... emphasize on putting forward the best of web development ... dedicated team of professionals and web developers and designers ... even the critical issues of web development and can ...
(Date:8/30/2014)... August 2014: Transvenous lead extraction (TLE) is clinically successful ... from the European Lead Extraction ConTRolled (ELECTRa) registry presented ... by Dr Maria Grazia Bongiorni, chair of the registry,s ... cardiac implantable electronic devices (CIED) implant procedures has grown ... of complications has increased and leads are often the ...
(Date:8/30/2014)... Top10BestSEOHosting.com is a well-known review website. ... HostGator.com http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts is the best Windows ... has announced that Bluehost and Arvixe are excellent ... of the Top 10 Web Hosting in 2014, ... and it offers rich features and great Windows ...
(Date:8/30/2014)... August 30, 2014 LiveStreamingFitness.com, a company dedicated ... other healthy lifestyle resources, is proud to announce it has ... for at home fitness solutions by ABC’s Good Morning America. ... story on ABC’s Good Morning America, “Live Streaming Fitness is ... streamline your day by streamlining your workout…to boot camp at ...
Breaking Medicine News(10 mins):Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:LiveStreamingFitness.com is New Trend In Fitness 2
... German . Tafamidis meglumine (trade name: Vyndaqel) ... in adults. This rare disorder ("orphan disease") is caused by a ... that tafamidis is supposed to delay. According to 35a SGB ... if a drug for a rare disease - known as an ...
... Boston, MA New Harvard School of Public Health (HSPH) ... tool in detecting early breast cancersmay in fact lead to ... have proved harmless. Based on a study of women in ... breast cancer cases are overdiagnosed. The study appears in ...
... HealthDay Reporter , WEDNESDAY, April 4 (HealthDay News) ... called flavonoids, such as berries, apples, tea and red wine, ... 40 percent, new research suggests. For women, however, a ... least several servings of berries a week, according to ...
... Dotinga HealthDay Reporter , WEDNESDAY, April 4 (HealthDay ... HIV vaccine failed to protect most people who received it, ... vaccine efforts. Scientists believe an HIV vaccine, designed to ... several years away. Tests of experimental vaccines have largely been ...
... of scientists, engineers and physicians from Brigham and ... Medical School (HMS), Massachusetts Institute of Technology (MIT), ... State University Karmanos Cancer Institute, and Weill Cornell ... first-in-class targeted cancer drug called BIND-014 in treating ...
... , WEDNESDAY, April 4 (HealthDay News) -- Nine physician specialty ... they believe are often overused or unnecessary, to help doctors ... came up with a list with five tests or procedures ... part of the ABIM Foundation,s Choosing Wisely campaign. ...
Cached Medicine News:Health News:Tafamidis: Approval denotes proven added benefit 2Health News:Routine mammograms may result in significant overdiagnosis of invasive breast cancer 2Health News:Berries, Tea May Cut Men's Odds for Parkinson's: Study 2Health News:Berries, Tea May Cut Men's Odds for Parkinson's: Study 3Health News:From a Failed Vaccine, New Insights Into Fighting HIV 2Health News:First targeted nanomedicine to enter human clinical studies 2Health News:First targeted nanomedicine to enter human clinical studies 3Health News:First targeted nanomedicine to enter human clinical studies 4Health News:Physician Groups Call for Fewer Medical Tests 2
(Date:8/29/2014)... /PRNewswire-iReach/ -- ChemImage will present a workshop focused on ... Forensic Science Society,s 22 nd International Symposium ... Australia .  Forensic Scientists will be in ... imaging can bring to examination procedures. ... Product Development at ChemImage, will host a workshop ...
(Date:8/29/2014)... and MENLO PARK, Calif. , ... Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced ... statements.  The Company recently changed its fiscal year end ... to list its common stock on a national securities ... financial statements as filed with the United States Securities ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces that ... its catalogue: North America Aesthetic Lasers ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North ... to 2020 Summary GlobalData,s new report, ... Outlook to 2020", provides key market data on ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16
... , , TROY, Mich., Jan. 8 ... for the fourth quarter and fiscal year ended November 30, 2009 ... In conjunction with releasing its financial results, the Company will ... a.m. (ET) the same day. , On the ...
... , , PRINCETON, N.J., ... management will present at the 28th Annual JPMorgan Healthcare Conference being ... Francis in San Francisco, CA. Schaefer Price, Pharmasset,s President and Chief ... conference on Thursday, January 14, 2010 at 2:00 PM (PT). , ...
Cached Medicine Technology:Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010 2Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference 2Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference 3
... eNclose Anastomosis Assist Device ... obviate the need for ... aorta. The enclose device ... with a stable, bloodless ...
15mm Open Blades, 30mm Maximum Blade Spread; in Titanium....
7mm Cross Hairs; Available in 4.5mm to 7.0mm in 0.5mm increments; Ring depth available from 2 to 4mm in 0.5mm increments.; in stainless steel....
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
Medicine Products: